Labcorp closes Personal Genome Diagnostics purchase

2020 09 08 18 51 2374 Business Handshake Meeting 400

Labcorp has completed its purchase of cancer genomics firm Personal Genome Diagnostics.

The addition of Personal Genome Diagnostics to Labcorp's roster complements its existing liquid biopsy offerings and expands its oncology portfolio of next-generation sequencing (NGS)-based genomic profiling, it said.

The deal closed on December 23, 2021.

Page 1 of 49
Next Page